Glaxosmithkline Pharmaceuticals reports 17% rise in Q4 net profit

20 May 2019 Evaluate

Glaxosmithkline Pharmaceuticals has reported results for fourth quarter and year ended March 31, 2019.

The company has reported a rise of 16.56% in its net profit at Rs 123.03 crore for the quarter under review as compared to Rs 105.55 crore for the same quarter in the previous year. Total income of the company increased by 4.81% at Rs 803.68 crore for Q4FY19 as compared Rs 766.77 crore for the corresponding quarter previous year.

For the year ended March 31, 2019, the company has reported a rise of 20.85% in its net profit at Rs 425.36 crore as compared to Rs 351.98 crore for the previous year. Total income of the company increased by 9.51% at Rs 3,230.01 crore for year under review as compared to Rs 2,949.40 crore for year ended March 31, 2018.

For the year ended March 31, 2019, on the consolidated basis, the company has reported a rise of 26.99% in its net profit at Rs 445.39 crore as compared to Rs 350.72 crore for the previous year. Total income of the company increased by 9.50% at Rs 3,230.44 crore for year under review as compared to Rs 2,950.19 crore for year ended March 31, 2018.

Glaxosmithkline Phar Share Price

1900.15 0.30 (0.02%)
18-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1523.80
Dr. Reddys Lab 5959.10
Cipla 1352.95
Zydus Lifesciences 934.50
Lupin 1599.65
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.